The standard online TRT panel is six to eight markers. Total testosterone. Free testosterone. Estradiol. Hematocrit. PSA. A basic lipid panel if you're lucky. That's the floor required to prescribe testosterone safely under most telehealth compliance frameworks. It is not the panel that determines whether your protocol will actually work.
The gap between "safe to prescribe" and "tuned to your biology" is roughly 40 markers wide. Here is what lives in that gap.
SHBG: the protein that decides if your testosterone is actually usable
Sex hormone binding globulin grabs onto testosterone in your bloodstream and locks it away from the cells that need it. When your physician orders Free T but not SHBG, they're measuring the unbound fraction without understanding why it's high or low. A patient with Total T of 700 and SHBG of 65 nmol/L feels like he has Total T of 350. Same hormone, different bioavailability.
SHBG goes up with thyroid disease, liver dysfunction, oral estrogens, and aging. It goes down with insulin resistance, obesity, and high androgen states. Treating low T without measuring SHBG means you're going to over- or under-dose somebody whose body is already telling you exactly what's wrong upstream.
The full thyroid panel — not just TSH
About 30 percent of low-T cases at KAYU have a thyroid component the patient didn't know about. The standard PCP panel runs TSH and calls it done. TSH is a brain signal, not a thyroid measurement. Your pituitary is asking your thyroid to work harder. It tells you nothing about whether the hormone was actually produced, whether T4 was converted to active T3, or whether your cells are receiving it.
The complete panel needs Free T4, Free T3, reverse T3, and (when symptoms warrant) thyroid antibodies. A patient with TSH of 3.1, Free T3 in the bottom quartile, and reverse T3 above 22 has a thyroid problem masquerading as low energy and low libido. Prescribe testosterone alone and you'll get a partial response that fades.
Fasting insulin: the silent driver of low testosterone
Insulin resistance crushes testosterone production. The mechanism is well-established: visceral fat upregulates aromatase, converting your testosterone to estradiol. Hyperinsulinemia suppresses SHBG and disrupts hypothalamic-pituitary-gonadal signaling. By the time fasting glucose drifts above 100, you've usually had decade-long metabolic dysfunction quietly suppressing your endocrine system.
Fasting insulin is not on a standard TRT panel. It should be. A man with insulin of 14 µIU/mL and Total T of 380 doesn't primarily need testosterone — he needs metabolic intervention first, with TRT as the augmenting layer once the underlying dysfunction is addressed.
Cortisol rhythm: why your "low T" feels worse some days than others
Adrenal output drives a circadian rhythm that influences sex hormone signaling. A flat or inverted cortisol curve — wired-at-bedtime, exhausted-at-wakeup — explains why some patients on identical TRT doses feel different week to week. A single morning cortisol draw misses this entirely. The four-point salivary cortisol test or DUTCH urine panel maps the rhythm.
Patients with HPA axis dysregulation respond better when stress physiology is addressed alongside hormone optimization, not after. Most TRT clinics never measure it.
The cardiovascular markers PSA + lipid panel skip
Standard cholesterol screening tracks LDL-C, HDL-C, and triglycerides. The actual cardiovascular risk markers in 2026 are ApoB (count of atherogenic particles), Lp(a) (genetic risk you only need to measure once), and hs-CRP (systemic inflammation). A patient on TRT with elevated hematocrit and high ApoB is at compounding cardiovascular risk that hematocrit alone won't reveal.
This matters specifically for TRT because testosterone elevates hematocrit, can shift lipids, and interacts with cardiovascular risk in ways that demand the modern markers. Running ApoB on a TRT patient is not optional in 2026.
Vitamin D, ferritin, B12, magnesium
Low vitamin D suppresses testosterone production directly. Low ferritin causes fatigue that mimics low-T symptoms and is endemic in male endurance athletes. B12 deficiency hits cognition first and looks identical to "low-T brain fog." RBC magnesium predicts sleep quality and arrhythmia risk.
Each of these costs about $15 to measure. Each can dramatically alter how a patient responds to TRT. None are on a standard six-marker panel.
The KAYU panel
The intake panel at KAYU runs 50+ markers across hormones, thyroid, metabolic function, cardiovascular risk, inflammation, micronutrients, and complete blood chemistry. Your physician interprets them as a system, not as isolated numbers. Your protocol is built from what the labs actually show — not from what fits the standard prescription template.
If your current TRT clinic told you your panel was "comprehensive" and ran fewer than 30 markers, you have an incomplete picture of your own physiology. The cost of running the full panel is modest. The cost of treating only what cheap testing reveals is years of suboptimal results.
Take the 2-minute KAYU assessment — your physician will review your goals, build a panel scoped to your biology, and explain every marker on your results. No upsell, no template.
This article is educational. It is not medical advice and does not substitute for a physician-patient relationship. Your KAYU clinician will interpret your specific results in the context of your full clinical picture.